Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1991 Apr;154(4):442–454.

Hypoglycemias.

F J Service 1
PMCID: PMC1002792  PMID: 1877184

Abstract

Low plasma glucose concentrations that may or may not be sufficiently low to result in symptoms can be observed as a concomitant of several diverse diseases. Treatment of the primary underlying disorder usually alleviates the hypoglycemia. For patients whose primary symptom is that of hypoglycemia, it is essential to confirm that the plasma glucose concentration is low during the occurrence of symptoms. Symptoms that occur after meals usually are mild and rarely signify serious disease. With rare exceptions, hypoglycemia resulting in major symptoms occurs in the food-deprived state. Lower concentrations of plasma insulin and C-peptide and a concomitant low plasma glucose are major clues to a correct diagnosis.

Full text

PDF
442

Images in this article

449Image
on p.449
450Image
on p.450
451Image
on p.451
451Image
on p.451
451Image
on p.451

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billington D., Osmundsen H., Sherratt H. S. Mechanisms of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid. In vitro studies. Biochem Pharmacol. 1978;27(24):2879–2890. doi: 10.1016/0006-2952(78)90204-6. [DOI] [PubMed] [Google Scholar]
  2. Brennan M. D., Service F. J., Carpenter A. M., Rubenstein A. H., Edis A. J. Diagnosis of pancreatic islet hyperplasia causing hypoglycemia in a patient with portacaval anastomosis. Am J Med. 1980 Jun;68(6):941–948. doi: 10.1016/0002-9343(80)90228-4. [DOI] [PubMed] [Google Scholar]
  3. Broder L. E., Carter S. K. Pancreatic islet cell carcinoma. I. Clinical features of 52 patients. Ann Intern Med. 1973 Jul;79(1):101–107. doi: 10.7326/0003-4819-79-1-101. [DOI] [PubMed] [Google Scholar]
  4. Daggett P. R., Goodburn E. A., Kurtz A. B., Le Quesne L. P., Morris D. V., Nabarro J. D., Raphael M. J. Is preoperative localisation of insulinomas necessary? Lancet. 1981 Feb 28;1(8218):483–486. doi: 10.1016/s0140-6736(81)91859-6. [DOI] [PubMed] [Google Scholar]
  5. De Pirro R., Roth R. A., Rossetti L., Goldfine I. D. Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities. Diabetes. 1984 Mar;33(3):301–304. doi: 10.2337/diab.33.3.301. [DOI] [PubMed] [Google Scholar]
  6. Dietze G., Wicklmayr M., Hepp K. D., Bogner W., Mehnert H., Czempiel H., Henftling H. G. On gluconeogenesis of human liver. Accelerated hepatic glucose formation induced by increased precursor supply. Diabetologia. 1976 Dec;12(6):555–561. doi: 10.1007/BF01220631. [DOI] [PubMed] [Google Scholar]
  7. Elias A. N., Gwinup G. Glucose-resistant hypoglycemia in inanition. Arch Intern Med. 1982 Apr;142(4):743–746. [PubMed] [Google Scholar]
  8. Faludi G., Bendersky G., Gerber P. Functional hypoglycemia in early latent diabetes. Ann N Y Acad Sci. 1968 Mar 26;148(3):868–874. doi: 10.1111/j.1749-6632.1968.tb27760.x. [DOI] [PubMed] [Google Scholar]
  9. Flier J. S., Bar R. S., Muggeo M., Kahn C. R., Roth J., Gorden P. The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemia. J Clin Endocrinol Metab. 1978 Nov;47(5):985–995. doi: 10.1210/jcem-47-5-985. [DOI] [PubMed] [Google Scholar]
  10. Folling I., Norman N. Hyperglycemia, hypoglycemic attacks, and production of anti-insulin antibodies without previous known immunization. Immunological and functional studies in a patient. Diabetes. 1972 Jul;21(7):814–826. doi: 10.2337/diab.21.7.814. [DOI] [PubMed] [Google Scholar]
  11. Fulton R. E., Sheedy P. F., McILRATH D. C., Ferris D. O. Preoperative angiographic localization of insulin-producing tumors of the pancreas. Am J Roentgenol Radium Ther Nucl Med. 1975 Feb;123(2):367–377. doi: 10.2214/ajr.123.2.367. [DOI] [PubMed] [Google Scholar]
  12. Garber A. J., Bier D. M., Cryer P. E., Pagliara A. S. Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis. Diabetes. 1974 Dec;23(12):982–986. doi: 10.2337/diab.23.12.982. [DOI] [PubMed] [Google Scholar]
  13. Goldman J., Baldwin D., Rubenstein A. H., Klink D. D., Blackard W. G., Fisher L. K., Roe T. F., Schnure J. J. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. J Clin Invest. 1979 May;63(5):1050–1059. doi: 10.1172/JCI109374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gorman B., Charboneau J. W., James E. M., Reading C. C., Galiber A. K., Grant C. S., van Heerden J. A., Telander R. L., Service F. J. Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR Am J Roentgenol. 1986 Nov;147(5):929–934. doi: 10.2214/ajr.147.5.929. [DOI] [PubMed] [Google Scholar]
  15. Grunberger G., Weiner J. L., Silverman R., Taylor S., Gorden P. Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up. Ann Intern Med. 1988 Feb;108(2):252–257. doi: 10.7326/0003-4819-108-2-252. [DOI] [PubMed] [Google Scholar]
  16. Harrop J. S., Golding P. R., Goodall P., Leveau V. M., Steele G. A., Ingle A. R. C-peptide suppression test and sulphonylurea-induced factitious hypoglycaemia. Br Med J (Clin Res Ed) 1982 Mar 27;284(6320):940–941. doi: 10.1136/bmj.284.6320.940-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haymond M. W., Ben-Galim E., Strobel K. E. Glucose and alanine metabolism in children with maple syrup urine disease. J Clin Invest. 1978 Aug;62(2):398–405. doi: 10.1172/JCI109141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hogan M. J., Service F. J., Sharbrough F. W., Gerich J. E. Oral glucose tolerance test compared with a mixed meal in the diagnosis of reactive hypoglycemia. A caveat on stimulation. Mayo Clin Proc. 1983 Aug;58(8):491–496. [PubMed] [Google Scholar]
  19. Huang S. C., Phelps M. E., Hoffman E. J., Sideris K., Selin C. J., Kuhl D. E. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol. 1980 Jan;238(1):E69–E82. doi: 10.1152/ajpendo.1980.238.1.E69. [DOI] [PubMed] [Google Scholar]
  20. Jaspan J. B., Wollman R. L., Bernstein L., Rubenstein A. H. Hypoglycemic peripheral neuropathy in association with insulinoma: implication of glucopenia rather than hyperinsulinism. Case report and literature review. Medicine (Baltimore) 1982 Jan;61(1):33–44. [PubMed] [Google Scholar]
  21. Johnson D. D., Dorr K. E., Swenson W. M., Service F. J. Reactive hypoglycemia. JAMA. 1980 Mar 21;243(11):1151–1155. [PubMed] [Google Scholar]
  22. Jordan R. M., Kammer H. An insulinoma without fasting hypoglycemia. Am J Med Sci. 1976 Sep-Oct;272(2):205–209. doi: 10.1097/00000441-197609000-00011. [DOI] [PubMed] [Google Scholar]
  23. Kahn C. R., Rosen S. W., Weintraub B. D., Fajans S. S., Gorden P. Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy. N Engl J Med. 1977 Sep 15;297(11):565–569. doi: 10.1056/NEJM197709152971101. [DOI] [PubMed] [Google Scholar]
  24. Kahn C. R., Rosenthal A. S. Immunologic reactions to insulin: insulin allergy, insulin resistance, and the autoimmune insulin syndrome. Diabetes Care. 1979 May-Jun;2(3):283–295. doi: 10.2337/diacare.2.3.283. [DOI] [PubMed] [Google Scholar]
  25. Kahn C. R. The riddle of tumour hypoglycaemia revisited. Clin Endocrinol Metab. 1980 Jul;9(2):335–360. doi: 10.1016/s0300-595x(80)80037-5. [DOI] [PubMed] [Google Scholar]
  26. Kumar D., Mehtalia S. D., Miller L. V. Diagnostic use of glucagon-induced insulin response. Studies in patients with insulinoma or other hypoglycemic conditions. Ann Intern Med. 1974 Jun;80(6):697–701. doi: 10.7326/0003-4819-80-6-697. [DOI] [PubMed] [Google Scholar]
  27. Lecavalier L., Bolli G., Cryer P., Gerich J. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol. 1989 Jun;256(6 Pt 1):E844–E851. doi: 10.1152/ajpendo.1989.256.6.E844. [DOI] [PubMed] [Google Scholar]
  28. Lev-Ran A., Anderson R. W. The diagnosis of postprandial hypoglycemia. Diabetes. 1981 Dec;30(12):996–999. doi: 10.2337/diab.30.12.996. [DOI] [PubMed] [Google Scholar]
  29. MCDONALD G. W., FISHER G. F., BURNHAM C. REPRODUCIBILITY OF THE ORAL GLUCOSE TOLERANCE TEST. Diabetes. 1965 Aug;14:473–480. doi: 10.2337/diab.14.8.473. [DOI] [PubMed] [Google Scholar]
  30. Mandarino L., Tsalikian E., Bartold S., Marsh H., Carney A., Buerklin E., Tutwiler G., Haymond M., Handwerger B., Rizza R. Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antiinsulin receptor antibodies. J Clin Endocrinol Metab. 1984 Oct;59(4):658–664. doi: 10.1210/jcem-59-4-658. [DOI] [PubMed] [Google Scholar]
  31. Marks V. Alcohol and carbohydrate metabolism. Clin Endocrinol Metab. 1978 Jul;7(2):333–349. doi: 10.1016/s0300-595x(78)80022-x. [DOI] [PubMed] [Google Scholar]
  32. McFadzean A. J., Yeung R. T. Further observations on hypoglycaemia in hepatocellular carcinoma. Am J Med. 1969 Aug;47(2):220–235. doi: 10.1016/0002-9343(69)90148-x. [DOI] [PubMed] [Google Scholar]
  33. McMahon M. M., O'Brien P. C., Service F. J. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. Mayo Clin Proc. 1989 Dec;64(12):1481–1488. doi: 10.1016/s0025-6196(12)65703-6. [DOI] [PubMed] [Google Scholar]
  34. Moertel C. G., Hanley J. A., Johnson L. A. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1980 Nov 20;303(21):1189–1194. doi: 10.1056/NEJM198011203032101. [DOI] [PubMed] [Google Scholar]
  35. Nelson R. L., Rizza R. A., Service F. J. Documented hypoglycemia for 23 years in a patient with insulinoma. JAMA. 1978 Oct 20;240(17):1891–1891. [PubMed] [Google Scholar]
  36. Owen O. E., Morgan A. P., Kemp H. G., Sullivan J. M., Herrera M. G., Cahill G. F., Jr Brain metabolism during fasting. J Clin Invest. 1967 Oct;46(10):1589–1595. doi: 10.1172/JCI105650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Palardy J., Havrankova J., Lepage R., Matte R., Bélanger R., D'Amour P., Ste-Marie L. G. Blood glucose measurements during symptomatic episodes in patients with suspected postprandial hypoglycemia. N Engl J Med. 1989 Nov 23;321(21):1421–1425. doi: 10.1056/NEJM198911233212101. [DOI] [PubMed] [Google Scholar]
  38. Permutt M. A. Postprandiol hypoglycemia. Diabetes. 1976 Aug;25(8):719–733. doi: 10.2337/diab.25.8.719. [DOI] [PubMed] [Google Scholar]
  39. Pun K. K., Young R. T., Wang C., Tam C. F., Ho P. W. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma. J Clin Endocrinol Metab. 1988 Sep;67(3):546–550. doi: 10.1210/jcem-67-3-546. [DOI] [PubMed] [Google Scholar]
  40. Radziuk J., McDonald T. J., Rubenstein D., Dupre J. Initial splanchnic extraction of ingested glucose in normal man. Metabolism. 1978 Jun;27(6):657–669. doi: 10.1016/0026-0495(78)90003-3. [DOI] [PubMed] [Google Scholar]
  41. Rizza R. A., Cryer P. E., Gerich J. E. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest. 1979 Jul;64(1):62–71. doi: 10.1172/JCI109464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rizza R. A., Haymond M. W., Verdonk C. A., Mandarino L. J., Miles J. M., Service F. J., Gerich J. E. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin. Diabetes. 1981 May;30(5):377–381. doi: 10.2337/diab.30.5.377. [DOI] [PubMed] [Google Scholar]
  43. Rizza R. A., Mandarino L. J., Gerich J. E. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab. 1982 Jan;54(1):131–138. doi: 10.1210/jcem-54-1-131. [DOI] [PubMed] [Google Scholar]
  44. Sandler R., Horwitz D. L., Rubenstein A. H., Kuzuya H. Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy. Am J Med. 1975 Nov;59(5):730–736. doi: 10.1016/0002-9343(75)90234-x. [DOI] [PubMed] [Google Scholar]
  45. Santiago J. V., Clarke W. L., Shah S. D., Cryer P. E. Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab. 1980 Oct;51(4):877–883. doi: 10.1210/jcem-51-4-877. [DOI] [PubMed] [Google Scholar]
  46. Schein P. S. Islet cell tumors: current concepts and management. Ann Intern Med. 1973 Aug;79(2):239–257. doi: 10.7326/0003-4819-79-2-239. [DOI] [PubMed] [Google Scholar]
  47. Seino S., Fu Z. Z., Marks W., Seino Y., Imura H., Vinik A. Characterization of circulating insulin in insulin autoimmune syndrome. J Clin Endocrinol Metab. 1986 Jan;62(1):64–69. doi: 10.1210/jcem-62-1-64. [DOI] [PubMed] [Google Scholar]
  48. Service F. J., Dale A. J., Elveback L. R., Jiang N. S. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976 Jul;51(7):417–429. [PubMed] [Google Scholar]
  49. Service F. J., Horwitz D. L., Rubenstein A. H., Kuzuya H., Mako M. E., Reynolds C., Molnar G. D. C-peptide suppression test for insulinoma. J Lab Clin Med. 1977 Jul;90(1):180–186. [PubMed] [Google Scholar]
  50. Stuart C. A., Prince M. J., Peters E. J., Smith F. E., Townsend C. M., 3rd, Poffenbarger P. L. Insulin receptor proliferation: a mechanism for tumor-associated hypoglycemia. J Clin Endocrinol Metab. 1986 Oct;63(4):879–885. doi: 10.1210/jcem-63-4-879. [DOI] [PubMed] [Google Scholar]
  51. Turner R. C., Heding L. G. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia. 1977 Dec;13(6):571–577. doi: 10.1007/BF01236309. [DOI] [PubMed] [Google Scholar]
  52. Vinik A. I., Deppe W. M. Studies on hypoglycaemia in primary carcinoma of the liver. A case report and review of pathogenetic mechanisms. S Afr Med J. 1974 Mar 31;47(12):518–524. [PubMed] [Google Scholar]
  53. Wasada T., Eguchi Y., Takayama S., Yao K. S., Hirata Y. Reverse phase high performance liquid chromatographic analysis of circulating insulin in the insulin autoimmune syndrome. J Clin Endocrinol Metab. 1988 Jan;66(1):153–158. doi: 10.1210/jcem-66-1-153. [DOI] [PubMed] [Google Scholar]
  54. Wilson N. M., Brown P. M., Juul S. M., Prestwich S. A., Sönksen P. H. Glucose turnover and metabolic and hormonal changes in ethanol-induced hypoglycaemia. Br Med J (Clin Res Ed) 1981 Mar 14;282(6267):849–853. doi: 10.1136/bmj.282.6267.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wiznitzer T., Shapira N., Stadler J., Ayalon D., Harell A. Late hypoglycemia in patients following vagotomy and pyloroplasty. Int Surg. 1974 Apr;59(4):229–232. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES